 |
|
|
| |
Real World SOF/VEL/VOX Retreatment Outcomes and Viral Resistance
Analysis for HCV Patients with Prior Failure to DAA Therapy
|
| |
| |
David A Smith1,2, Daniel Bradshaw3, Jean Mbisa3, Carmen F Manso3, David Bibby3, Josh Singer4, Emma Thomson4, Ana Filipe4, Elihu Aranday-
Cortes4, M. Azim Ansari1, Anthony Brown1, Emma Hudson1, Jennifer Benselin5, Brendan Healy6, Phil Troke7, STOP-HCV Consortium, HCV Research
UK, John McLauchlan4, Eleanor Barnes1,2, William L Irving5
1. Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford
2. Oxford NIHR Biomedical Research Centre
3. National Infection Service, Public Health England
4. MRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH
5. NIHR Biomedical Research Centre (BRC), Nottingham University Hospitals NHS Trust and the
University of Nottingham, Nottingham, UK
6. Public Health Wales Microbiology Cardiff, University Hospital of Wales
7. Gilead Sciences Ltd., London
|
| |
|
|
|
|
|
